[Enteral contrast agents-When, what and how?]

IF 0.6
Lukas Müller, Jana Korb, Tobias Bäuerle, Tobias Jorg
{"title":"[Enteral contrast agents-When, what and how?]","authors":"Lukas Müller, Jana Korb, Tobias Bäuerle, Tobias Jorg","doi":"10.1007/s00117-026-01671-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Administration of enteral contrast media (CM) in abdominal computed tomography (CT) is handled inconsistently across Germany.</p><p><strong>Objective: </strong>To present the current recommendations on administration of enteral contrast agents along the guiding questions of when, what and how and to translate them into radiological practice.</p><p><strong>Material and methods: </strong>Synthesis of indication-based recommendations, CM classes and their technical properties and the practical execution of both routes of administration, based on the recommendations of the German Röntgen Society (DRG), current guidelines, published evidence and institutional practice.</p><p><strong>Results: </strong>Positive oral CMs are obsolete for most abdominal indications, including acute abdomen, ileus and trauma, and are contraindicated when gastrointestinal bleeding or ischemia is suspected. In cases of suspected perforation, routine oral contrast agents should be omitted and barium sulphate is contraindicated, whereas water-soluble iodinated agents remain an option when a leak has to be specifically demonstrated. Furthermore, enteral contrasting with neutral oral CM remains useful for upper gastrointestinal tumor staging and enterography (preferably magnetic resonance enterography).</p><p><strong>Conclusion: </strong>An indication-appropriate, guideline-based enteral contrast agent administration reduces unnecessary burden without compromising diagnostic accuracy and should be embedded in standardized workflows.</p>","PeriodicalId":74635,"journal":{"name":"Radiologie (Heidelberg, Germany)","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2026-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiologie (Heidelberg, Germany)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00117-026-01671-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Administration of enteral contrast media (CM) in abdominal computed tomography (CT) is handled inconsistently across Germany.

Objective: To present the current recommendations on administration of enteral contrast agents along the guiding questions of when, what and how and to translate them into radiological practice.

Material and methods: Synthesis of indication-based recommendations, CM classes and their technical properties and the practical execution of both routes of administration, based on the recommendations of the German Röntgen Society (DRG), current guidelines, published evidence and institutional practice.

Results: Positive oral CMs are obsolete for most abdominal indications, including acute abdomen, ileus and trauma, and are contraindicated when gastrointestinal bleeding or ischemia is suspected. In cases of suspected perforation, routine oral contrast agents should be omitted and barium sulphate is contraindicated, whereas water-soluble iodinated agents remain an option when a leak has to be specifically demonstrated. Furthermore, enteral contrasting with neutral oral CM remains useful for upper gastrointestinal tumor staging and enterography (preferably magnetic resonance enterography).

Conclusion: An indication-appropriate, guideline-based enteral contrast agent administration reduces unnecessary burden without compromising diagnostic accuracy and should be embedded in standardized workflows.

肠内造影剂-何时,使用什么,如何使用?]
背景:在德国,腹部计算机断层扫描(CT)中肠内造影剂(CM)的使用不一致。目的:介绍目前关于肠内造影剂使用的建议,以及何时、使用什么和如何使用的指导问题,并将其转化为放射实践。材料和方法:基于德国Röntgen协会(DRG)的建议、现行指南、已发表的证据和机构实践,综合基于适应症的建议、CM类别及其技术特性和两种给药途径的实际执行。结果:大多数腹部适应症,包括急腹症、肠梗阻和创伤,口服CMs阳性已过时,当怀疑胃肠道出血或缺血时禁用。在疑似穿孔的情况下,常规口服造影剂应省略,硫酸钡是禁忌,而水溶性碘剂仍然是一种选择,当泄漏必须明确证明。此外,肠内对比与中性口服CM仍然有助于上胃肠道肿瘤分期和肠造影(最好是磁共振肠造影)。结论:适合适应症的、基于指南的肠内造影剂给药在不影响诊断准确性的情况下减少了不必要的负担,应纳入标准化工作流程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书